Johnson & Johnson, Teva and other drug manufacturers won a bench decision in an opioid crisis trial in California, after the judge ruled there was no evidence linking the companies'…
The first generic version of Chantix has been announced just days after a complete recall of the brand name smoking cessation drug.
Endo International has finalized a Testim testosterone gel settlement agreement which will resolve about 1,300 lawsuits over heart attack and stroke injury claims.
A proposed settlement could resolve all testosterone lawsuits filed by users of Testim, claiming to have suffered heart attacks, strokes and other side effects.
An Opana ER lawsuit filed by Kentucky claims that Endo Pharmaceutical illegally marketed a dangerous drug that resulted in 191 deaths last year.
The first bellwether trial involving claims that the side effects of Testim, the testosterone gel, caused a man's heart attack has survived a summary judgment effort by Auxilium and will…
Endo Pharmaceuticals plans to pay nearly $800 million to resolve thousands of remaining vaginal mesh lawsuits.
The FDA will soon roll out new education requirements for doctors prescribing opioid painkillers, in the face of an ongoing national drug abuse epidemic.
The FDA is calling for an Opana ER recall after determining that the risk of abuse outweighs any benefits, linking the drug to outbreaks of HIV and hepatitis C.
A panel of FDA advisers is calling for an Opana ER recall, saying the drug's risks outweigh the benefits after abusers found a way to defeat its "abuse-deterrent" design by…
